UK:
CJEU Overturns Neurim – No SPCs For New Therapeutic Uses Of Old Active Ingredients
13 July 2020
J A Kemp LLP
To print this article, all you need is to be registered or login on Mondaq.com.
The CJEU issued on 9 July 2020 its judgment in the Santen
C-673/18 case. The judgment, which is reviewed in more detail in
our briefing (here), overturns the earlier Neurim decision
and concludes that SPCs are not available for new therapeutic uses
of old active ingredients.
Originally published 10 July 2020.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Litigation, Mediation & Arbitration from UK
Muddy Waters: Flooding And The Law Of Nuisance
Shepherd and Wedderburn LLP
This article looks at the circumstances in which there may be a claim under the law of nuisance if flooding is attributable to the use that a neighbouring landowner is making of their land.
Rule Changes Regarding Penal Notices
Herbert Smith Freehills
On 6 April 2024, an amendment to the Civil Procedure Rules came into force regarding penal notices – that is, notices given to persons served with a court order warning them that breach of the order may be punishable...